Cell & Developmental Biology
Open Access
ISSN: 2168-9296
ISSN: 2168-9296
Eden Rebecca Padayachee
Department of Neurochemistry
University of Gothenburg, Gothenburg, Sweden
Dr. Eden Rebecca Padayachee is currently a post-doctoral fellow at the Institute of Neuroscience & Physiology in Gothenburg, Sweden. She received her Ph.D in Medicinal Biochemistry from Rhodes University, South Africa and possesses over 5 years of experience in enzymology, amyloid-beta aggregation and biomarker discovery. The title of her dissertation was ?biochemical mechanisms of Alzheimer?s disease.? She is a scientific discoverer and innovator and was commented on by a thesis examiner, who said off her ?This candidate?s discovery could be very important in the Alzheimer?s field and may be the most impactful result of this work. She should be complimented on her methodological expertise and tenacity.? She was recently selected as one of the top 15 candidates out of 300 to attend a 5 day boot camp at the BioMed-X GmbH in Heidelberg, Germany, targeting tau-mediated neurodegeneration in Alzheimer's disease. Her objective is open up her own pharmaceutical company specializing in biomarker discovery, related to enzymes as biosensors and the use of nanovehicles e.g. endogenous protein or lipid based particles that have regenerative properties. Her hobbies include writing a book entitled ?How to become a visionary and be your own catalyst for positive change right now?. She is a master at writing her own powerful quotations to inspire others to reach their full potential. She has been personally invited as guest speaker at the Alzheimer?s Association, UK; International Woman?s Club, Sweden and neuroscience conferences in South Africa, Thailand, China, America and Denmark, resulting in the creation of a global knowledge hub in Alzheimer?s research and innovative therapeutic strategies.
Dr. Eden Rebecca Padayachee is currently a post-doctoral fellow at the Institute of Neuroscience & Physiology in Gothenburg, Sweden. She received her Ph.D in Medicinal Biochemistry from Rhodes University, South Africa and possesses over 5 years of experience in enzymology, amyloid-beta aggregation and biomarker discovery. The title of her dissertation was ?biochemical mechanisms of Alzheimer?s disease.? She is a scientific discoverer and innovator and was commented on by a thesis examiner, who said off her ?This candidate?s discovery could be very important in the Alzheimer?s field and may be the most impactful result of this work. She should be complimented on her methodological expertise and tenacity.? She was recently selected as one of the top 15 candidates out of 300 to attend a 5 day boot camp at the BioMed-X GmbH in Heidelberg, Germany, targeting tau-mediated neurodegeneration in Alzheimer's disease. Her objective is open up her own pharmaceutical company specializing in biomarker discovery, related to enzymes as biosensors and the use of nanovehicles e.g. endogenous protein or lipid based particles that have regenerative properties. Her hobbies include writing a book entitled ?How to become a visionary and be your own catalyst for positive change right now?. She is a master at writing her own powerful quotations to inspire others to reach their full potential. She has been personally invited as guest speaker at the Alzheimer?s Association, UK; International Woman?s Club, Sweden and neuroscience conferences in South Africa, Thailand, China, America and Denmark, resulting in the creation of a global knowledge hub in Alzheimer?s research and innovative therapeutic strategies.